Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Concentrations of circulating immune complexes (CIC) were measured serially during chemotherapy of 22 patients with gestational trophoblastic tumours (GTT) and 11 patients with malignant teratoma (MT) by the polyethylene glycol precipitation and CIq solid-phase assays. Results were correlated with tumour response as measured by serum concentrations of human chorionic gonadotrophin (hCG) and alpha-foetoprotein (AFP). CIC concentrations correlated with disease status in the early stages of treatment in 4/22 patients with GTT and 5/11 with MT. CIC assays were less sensitive than hCG and AFP as a monitor of disease, and also less specific, in that 8 patients with GTT and 5 with MT developed raised CIC concentrations during chemotherapy in spite of sustained complete remission. Measurements of CIC concentrations by present methods are neither sufficiently sensitive nor specific to be of clinical value as a tumour marker in GTT and MT, and this casts doubt on their potential value in other malignancies. Attention should be directed to identification of the components of CIC, some of which may be more cancer-specific.
D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis*; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D013724:Teratoma / Q000188:drug therapy / Q000276:immunology*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000276:immunology; D014328:Trophoblastic Neoplasms / Q000188:drug therapy / Q000276:immunology*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000276:immunology*; D000509:alpha-Fetoproteins / Q000378:metabolism
D000936:Antigen-Antibody Complex; D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins